Tafur Alfonso J, Barnes Geoffrey D, Bhagirath Vinai C, Douketis James
Department of Medicine, Vascular Medicine, NorthShore-Edward-Elmhurst Health, Evanston, Illinois, United States.
Department of Medicine-Cardiovascular Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States.
TH Open. 2024 Mar 11;8(1):e114-e120. doi: 10.1055/a-2259-0911. eCollection 2024 Jan.
Lack of alignment of care protocols among providers in health care is a driver of increased costs and suboptimal patient outcomes. Perioperative anticoagulation management is a good example of a complex area where protocol creation is a clinical challenge that demands input from multiple experts. Questions regarding the need for anticoagulation interruptions are frequent. Yet, due to layers of complexity involving analysis of anticoagulation indication, surgical risk, and anesthesia-associated bleeding risk as well as institutional practices, there is heterogeneity in how these interruptions are approached. The recent perioperative anticoagulation guidelines from the American College of Chest Physicians summarize extensive evidence for the management of anticoagulant and antiplatelet medications in patients who undergo elective interventions. However, implementation of these guidelines by individual clinicians is highly varied and often does not follow the best available clinical evidence. Against this background, anticoagulation stewardship units, which exist to improve safety and quality monitoring for the anticoagulated patient, are of growing interest. These units provide a bridge for the implementation of value-based, high-quality guidelines for patients who need perioperative anticoagulation interruption. We use a case to pragmatically illustrate the problem and tactics for change management and implementation science that may facilitate the adoption of perioperative anticoagulation guidelines.
医疗保健机构中医疗服务提供者之间护理协议缺乏一致性,是成本增加和患者预后欠佳的一个驱动因素。围手术期抗凝管理就是一个复杂领域的典型例子,在这个领域制定协议是一项临床挑战,需要多位专家的参与。关于是否需要中断抗凝治疗的问题很常见。然而,由于涉及抗凝指征分析、手术风险、麻醉相关出血风险以及机构实践等多层面的复杂性,在处理这些中断的方式上存在异质性。美国胸科医师学会最近发布的围手术期抗凝指南总结了接受择期手术患者抗凝和抗血小板药物管理的大量证据。然而,个体临床医生对这些指南的实施差异很大,而且往往没有遵循最佳可得临床证据。在此背景下,旨在改善抗凝患者安全和质量监测的抗凝管理单元越来越受到关注。这些单元为需要围手术期中断抗凝治疗的患者实施基于价值的高质量指南提供了桥梁。我们通过一个案例切实说明可能有助于采用围手术期抗凝指南的问题以及变革管理和实施科学的策略。